252 related articles for article (PubMed ID: 25569660)
21. Use of proton-pump inhibitors in complicated ulcer disease and upper gastrointestinal tract bleeding.
Howden CW
Am J Health Syst Pharm; 1999 Dec; 56(23 Suppl 4):S5-11. PubMed ID: 10597118
[TBL] [Abstract][Full Text] [Related]
22. Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients.
Asaka M; Kato M; Sugiyama T; Satoh K; Kuwayama H; Fukuda Y; Fujioka T; Takemoto T; Kimura K; Shimoyama T; Shimizu K; Kobayashi S;
J Gastroenterol; 2003; 38(4):339-47. PubMed ID: 12743773
[TBL] [Abstract][Full Text] [Related]
23. Lower Helicobacter pylori infection rate in chronic kidney disease and end-stage renal disease patients with peptic ulcer disease.
Chang SS; Hu HY
J Chin Med Assoc; 2014 Jul; 77(7):354-9. PubMed ID: 24907021
[TBL] [Abstract][Full Text] [Related]
24. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
Lai KC; Chu KM; Hui WM; Wong BC; Hu WH; Wong WM; Chan AO; Wong J; Lam SK
Am J Med; 2005 Nov; 118(11):1271-8. PubMed ID: 16271912
[TBL] [Abstract][Full Text] [Related]
25. Does Helicobacter pylori Eradication Reduce the Risk of Open Angle Glaucoma in Patients With Peptic Ulcer Disease?
Chen HY; Lin CL; Chen WC; Kao CH
Medicine (Baltimore); 2015 Sep; 94(39):e1578. PubMed ID: 26426633
[TBL] [Abstract][Full Text] [Related]
26. Usefulness of proton pump inhibitor (PPI) maintenance therapy for patients with H. pylori-negative recurrent peptic ulcer after eradication therapy for H. pylori: pathophysiological characteristics of H. pylori-negative recurrent ulcer scars and beyond acid suppression by PPI.
Ohara T; Morishita T; Suzuki H; Masaoka T; Ishii H
Hepatogastroenterology; 2004; 51(56):338-42. PubMed ID: 15086153
[TBL] [Abstract][Full Text] [Related]
27. H. pylori eradication therapy vs. antisecretory non-eradication therapy (with or without long-term maintenance antisecretory therapy) for the prevention of recurrent bleeding from peptic ulcer.
Gisbert JP; Khorrami S; Carballo F; Calvet X; Gené E; Dominguez-Muñoz JE
Cochrane Database Syst Rev; 2004; (2):CD004062. PubMed ID: 15106235
[TBL] [Abstract][Full Text] [Related]
28. H. pylori eradication therapy vs. antisecretory non-eradication therapy (with or without long-term maintenance antisecretory therapy) for the prevention of recurrent bleeding from peptic ulcer.
Gisbert JP; Khorrami S; Carballo F; Calvet X; Gené E; Dominguez-Muñoz JE
Cochrane Database Syst Rev; 2003; (4):CD004062. PubMed ID: 14584003
[TBL] [Abstract][Full Text] [Related]
29. Evidence-based clinical practice guidelines for peptic ulcer disease 2015.
Satoh K; Yoshino J; Akamatsu T; Itoh T; Kato M; Kamada T; Takagi A; Chiba T; Nomura S; Mizokami Y; Murakami K; Sakamoto C; Hiraishi H; Ichinose M; Uemura N; Goto H; Joh T; Miwa H; Sugano K; Shimosegawa T
J Gastroenterol; 2016 Mar; 51(3):177-94. PubMed ID: 26879862
[TBL] [Abstract][Full Text] [Related]
30. Critical issues in the pathophysiology and management of peptic ulcer disease.
Hunt RH; Malfertheiner P; Yeomans ND; Hawkey CJ; Howden CW
Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):685-99. PubMed ID: 8590166
[TBL] [Abstract][Full Text] [Related]
31. What consideration should be given to Helicobacter pylori in treating nonsteroidal anti-inflammatory drug ulcers?
Hawkey CJ
Eur J Gastroenterol Hepatol; 2000 Jun; 12 Suppl 1():S17-20. PubMed ID: 10929894
[TBL] [Abstract][Full Text] [Related]
32. Meta-analysis: role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users.
Vergara M; Catalán M; Gisbert JP; Calvet X
Aliment Pharmacol Ther; 2005 Jun; 21(12):1411-8. PubMed ID: 15948807
[TBL] [Abstract][Full Text] [Related]
33. Successful eradication of Helicobacter pylori prevents relapse of peptic ulcer disease.
Tomita T; Fukuda Y; Tamura K; Tanaka J; Hida N; Kosaka T; Hori K; Sakagami T; Satomi M; Shimoyama T
Aliment Pharmacol Ther; 2002 Apr; 16 Suppl 2():204-9. PubMed ID: 11966543
[TBL] [Abstract][Full Text] [Related]
34. Maintenance therapy with H2-receptor antagonist until assessment of Helicobacter pylori eradication can reduce recurrence of peptic ulcer after successful eradication of the organism: prospective randomized controlled trial.
Murakami K; Sato R; Okimoto T; Watanabe K; Nasu M; Kodama M; Fujioka T
J Gastroenterol Hepatol; 2006 Jun; 21(6):1048-53. PubMed ID: 16724993
[TBL] [Abstract][Full Text] [Related]
35. Randomised trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers.
Chan FK; Sung JJ; Chung SC; To KF; Yung MY; Leung VK; Lee YT; Chan CS; Li EK; Woo J
Lancet; 1997 Oct; 350(9083):975-9. PubMed ID: 9329511
[TBL] [Abstract][Full Text] [Related]
36. Eradication of Helicobacter pylori for prevention of ulcer recurrence after simple closure of perforated peptic ulcer: a meta-analysis of randomized controlled trials.
Wong CS; Chia CF; Lee HC; Wei PL; Ma HP; Tsai SH; Wu CH; Tam KW
J Surg Res; 2013 Jun; 182(2):219-26. PubMed ID: 23158404
[TBL] [Abstract][Full Text] [Related]
37. Eradication of Helicobacter pylori does not reduce the incidence of gastroduodenal ulcers in patients on long-term NSAID treatment: double-blind, randomized, placebo-controlled trial.
de Leest HT; Steen KS; Lems WF; Bijlsma JW; van de Laar MA; Huisman AM; Vonkeman HE; Houben HH; Kadir SW; Kostense PJ; van Tulder MW; Kuipers EJ; Boers M; Dijkmans BA
Helicobacter; 2007 Oct; 12(5):477-85. PubMed ID: 17760715
[TBL] [Abstract][Full Text] [Related]
38. Review article: clinical aspects of Helicobacter pylori eradication therapy in peptic ulcer disease.
Penston JG
Aliment Pharmacol Ther; 1996 Aug; 10(4):469-86. PubMed ID: 8853751
[TBL] [Abstract][Full Text] [Related]
39. Mental vulnerability, Helicobacter pylori, and incidence of hospital-diagnosed peptic ulcer over 28 years in a population-based cohort.
Levenstein S; Jacobsen RK; Rosenstock S; Jørgensen T
Scand J Gastroenterol; 2017 Sep; 52(9):954-961. PubMed ID: 28503971
[TBL] [Abstract][Full Text] [Related]
40. [Peptic ulcer recurrence after successful eradication of Helicobacter pylori--clinical characteristics and management].
Watanabe T; Higuchi K; Tominaga K; Fujiwara Y; Arakawa T
Nihon Rinsho; 2004 Mar; 62(3):495-8. PubMed ID: 15038093
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
